Company: CWAN
Filing Date: 2025-01-13
Form Type: 425
Source: 0001193125-25-004988
Chunk: 148

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-01-13
Form: 425
Chunk 148
---
 true and correct would not reasonably be expected to result in additional cost, expense or liability to Parent that would be more than de minimis,
(iii) the representations and warranties of the Company set forth in (Absence of Certain Changes) shall be true and correct in all respects as of the date of this Agreement and on the Closing
Date as if made on such date and (iv) the other representations and warranties of the Company set forth in shall be true and correct (disregarding for this purpose all “Company Material Adverse Effect,”
“materiality” and similar qualifications contained in such representations and warranties) as of the date of this Agreement and on the Closing Date as if made on such date (except to the extent that any such representation and warranty
expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct only as of such earlier date), except where the failure of such representations and warranties to be so true and correct would not,
individually or in the aggregate, have a Company Material Adverse Effect;

(b) the Company shall have performed in all material respects
or complied in all material respects with all obligations required to be performed or complied with by it under this Agreement at or prior to the Closing;

(c) Parent shall have received at the Closing a certificate signed on behalf of the Company by an authorized officer of the Company certifying
that the conditions set forth in , and have been satisfied;

(d) no Company Material Adverse Effect shall have occurred since the date hereof;

(e) (i) no Burdensome Condition shall be a condition to receipt of the Regulatory Approval, (ii) there shall not be in effect at or upon
the Closing any Order or Applicable Law resulting, individually or in the aggregate, in a Burdensome Condition and (iii) no Regulatory Approval shall contain, include or impose any Burdensome Condition; and

(f) the TRA Amendment shall be in full force and effect in accordance with its terms and otherwise shall not have been amended, repudiated,
revoked or withdrawn.

Section 7.03 Conditions to the Obligations of the Company. The obligation of the Company to
consummate the Mergers is subject to the satisfaction, or waiver by the Company, at or prior to Closing, of the following conditions:

101

(a) (i) the representations and warranties of Parent, Acquirer, Merger Sub and Merger Sub II
set forth in the first and second sentences of (